Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by johannnon Apr 05, 2022 5:25pm
228 Views
Post# 34578325

RE:Important Data Points - CR for Evaluable Patients

RE:Important Data Points - CR for Evaluable Patients
TSX-V - V 10.0 0.315 · 0.32 7.0 0.315 -0.145 -31.5 1,557.7 563 353 0.41  0.415  0.315 0.48  0.165 15:59:51   15 min
NEO ATS - U   0.32 -0.14 -30.4 566.0 200 156 0.41  0.41  0.32   15:58:14   15 min
Alpha - A   0.315 -0.145 -31.5 1,012.5 362 164 0.40  0.415  0.315   15:49:40   15 min
Omega - O   0.315 -0.145 -31.5 455.5 164 123 0.40  0.41  0.315   15:59:53   15 min
Pure - P   0.46     3.6 1 15        Mar 24   15 min
Chi-X - X   0.32 -0.14 -30.4 16.0 6 14 0.38  0.38  0.32   15:41:11   15 min
CX2 - H   0.315 -0.145 -31.5 827.4 294 284 0.41  0.41  0.315   15:59:45   15 min
CXD - D
 

<< Previous
Bullboard Posts
Next >>